Search fresh public links, source activity, and post angles for Botulinum Toxin.
Fresh curated links around botulinum toxin are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.
The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.
Agency requests additional manufacturing information and does not cite safety or efficacy concerns or require new clinical studies.
In an innovative stride toward mitigating postoperative complications in colorectal surgery, recent research has illuminated the promising role of intrasphincteric botulinum toxin...
Ipsen has shared phase 2 data on its long-acting neurotoxin, reporting an increase in the proportion of people with significant improvements in frown lines 24 weeks after treatment...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.